T cell immunity to dengue virus and implications for vaccine design

References

• Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–507.
   PubMed Web of Science ®Google Scholar
• Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7–16.
   PubMed Web of Science ®Google Scholar
• Beatty PR, Puerta-Guardo H, Killingbeck SS, et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med. 2015;7(304):304ra141.
   PubMed Web of Science ®Google Scholar
• Gamble J, Bethell D, Day NP, et al. Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Lond). 2000;98(2):211–216.
   PubMed Web of Science ®Google Scholar
• Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg. 1952;1(1):30–50.
   PubMedGoogle Scholar
• Snow GE, Haaland B, Ooi EE, et al. Review article: research on dengue during World War II revisited. Am J Trop Med Hyg. 2014;91(6):1203–1217.
   PubMed Web of Science ®Google Scholar
• Thein S, Aung MM, Shwe TN, et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg. 1997;56(5):566–572.
   PubMed Web of Science ®Google Scholar
• Graham RR, Juffrie M, Tan R, et al. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. Studies in 1995–1996. Am J Trop Med Hyg. 1999;61(3):412–419.
   PubMed Web of Science ®Google Scholar
• Burke DS, Nisalak A, Johnson DE, et al. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38(1):172–180.
   PubMed Web of Science ®Google Scholar
• Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol. 1984;120(5):653–669.
   PubMed Web of Science ®Google Scholar
• Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239(4839):476–481.
   PubMed Web of Science ®Google Scholar
• Simmons CP, Chau TN, Thuy TT, et al. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis. 2007;196(3):416–424.
   PubMed Web of Science ®Google Scholar
• Halstead SB, Rojanasuphot S, Sangkawibha N. Original antigenic sin in dengue. Am J Trop Med Hyg. 1983;32(1):154–156.
   PubMed Web of Science ®Google Scholar
• Mathew A, Townsley E, Ennis FA. Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections. Future Microbiol. 2014;9(3):411–425.
   PubMed Web of Science ®Google Scholar
• Khor CC, Chau TN, Pang J, et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet. 2011;43(11):1139–1141.
   PubMed Web of Science ®Google Scholar
• Bennett SN, Holmes EC, Chirivella M, et al. Selection-driven evolution of emergent dengue virus. Mol Biol Evol. 2003;20(10):1650–1658.
   PubMed Web of Science ®Google Scholar
• Gubler DJ, Reed D, Rosen L, et al. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg. 1978;27(3):581–589.
   PubMed Web of Science ®Google Scholar
• Steel A, Gubler DJ, Bennett SN. Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago. Virology. 2010;405(2):505–512.
   PubMed Web of Science ®Google Scholar
• Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003;9(7):921–927.
   PubMed Web of Science ®Google Scholar
• Duangchinda T, Dejnirattisai W, Vasanawathana S, et al. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci U S A. 2010;107(39):16922–16927.
   PubMed Web of Science ®Google Scholar
• Zivna I, Green S, Vaughn DW, et al. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol. 2002;168(11):5959–5965.
   PubMed Web of Science ®Google Scholar
• Mongkolsapaya J, Duangchinda T, Dejnirattisai W, et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol. 2006;176(6):3821–3829.
   PubMed Web of Science ®Google Scholar
• Friberg H, Burns L, Woda M, et al. Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol Cell Biol. 2011;89(1):122–129.
   PubMed Web of Science ®Google Scholar
• Imrie A, Meeks J, Gurary A, et al. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J Virol. 2007;81(18):10081–10091.
   PubMed Web of Science ®Google Scholar
• Bashyam HS, Green S, Rothman AL. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol. 2006;176(5):2817–2824.
   PubMed Web of Science ®Google Scholar
• Zivny J, DeFronzo M, Jarry W, et al. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J Immunol. 1999;163(5):2754–2760.
   PubMed Web of Science ®Google Scholar
• Mangada MM, Rothman AL. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol. 2005;175(4):2676–2683.
   PubMed Web of Science ®Google Scholar
• An J, Zhou DS, Zhang JL, et al. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunol Lett. 2004;95(2):167–174.
   PubMed Web of Science ®Google Scholar
• Dung NT, Duyen HT, Thuy NT, et al. Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol. 2010;184(12):7281–7287.
   PubMed Web of Science ®Google Scholar
• Simmons CP, Dong T, Chau NV, et al. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol. 2005;79(9):5665–5675.
   PubMed Web of Science ®Google Scholar
• Friberg H, Bashyam H, Toyosaki-Maeda T, et al. Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans. Sci Rep. 2011;1:51.
   PubMed Web of Science ®Google Scholar
• Townsley E, Woda M, Thomas SJ, et al. Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection. Immunology. 2014;141(1):27–38.
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Angelo MA, de Azeredo EL, et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci U S A. 2013;110(22):E2046–2053.
   PubMed Web of Science ®Google Scholar
• Rivino L, Kumaran EA, Thein TL, et al. Virus-specific T lymphocytes home to the skin during natural dengue infection. Sci Transl Med. 2015;7(278):278ra235.
   Web of Science ®Google Scholar
• Hatch S, Endy TP, Thomas S, et al. Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis. 2011;203(9):1282–1291.
   PubMed Web of Science ®Google Scholar
• Green S, Kurane I, Edelman R, et al. Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination. J Virol. 1993;67(10):5962–5967.
   PubMed Web of Science ®Google Scholar
• Kurane I, Innis BL, Nisalak A, et al. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest. 1989;83(2):506–513.
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Bangs DJ, Sidney J, et al. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc Natl Acad Sci U S A. 2015;112(31):E4256–4263.
   PubMed Web of Science ®Google Scholar
• Zompi S, Santich BH, Beatty PR, et al. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol. 2012;188(1):404–416.
   PubMed Web of Science ®Google Scholar
• Yauch LE, Zellweger RM, Kotturi MF, et al. A protective role for dengue virus-specific CD8+ T cells. J Immunol. 2009;182(8):4865–4873.
   PubMed Web of Science ®Google Scholar
• Yauch LE, Prestwood TR, May MM, et al. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol. 2010;185(9):5405–5416.
   PubMed Web of Science ®Google Scholar
• Prestwood TR, Morar MM, Zellweger RM, et al. Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha/beta receptor-deficient mice. J Virol. 2012;86(23):12561–12570.
   PubMed Web of Science ®Google Scholar
• Zellweger RM, Tang WW, Eddy WE, et al. CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice. J Virol. 2015;89(12):6494–6505.
   PubMed Web of Science ®Google Scholar
• Rivino L, Tan AT, Chia A, et al. Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity. J Immunol. 2013;191(8):4010–4019.
   PubMed Web of Science ®Google Scholar
• Rivino L, Kumaran EA, Jovanovic V, et al. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue infection. J Virol. 2013;87(5):2693–2706.
   Web of Science ®Google Scholar
• Weiskopf D, Yauch LE, Angelo MA, et al. Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J Immunol. 2011;187(8):4268–4279.
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Cerpas C, Angelo MA, et al. Human CD8+ T-cell responses against the four dengue virus serotypes are associated with distinct patterns of protein targets. J Infect Dis. 2015;212(11):1743–1751.
   PubMed Web of Science ®Google Scholar
• Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158(7):1445–1459.
   PubMed Web of Science ®Google Scholar
• Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature. 1998;394(6692):482–485.
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Butcher EC. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med. 2002;195(1):135–141.
   PubMed Web of Science ®Google Scholar
• Appanna R, Ponnampalavanar S, Lum Chai See L, et al. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS One. 2010;5(9). pii:e13029.
   PubMed Web of Science ®Google Scholar
• Loke H, Bethell DB, Phuong CX, et al. Strong HLA class I–restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis. 2001;184(11):1369–1373.
   PubMed Web of Science ®Google Scholar
• Malavige GN, Rostron T, Rohanachandra LT, et al. HLA class I and class II associations in dengue viral infections in a Sri Lankan population. PLoS One. 2011;6(6):e20581.
   PubMed Web of Science ®Google Scholar
• Stephens HA, Klaythong R, Sirikong M, et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens. 2002;60(4):309–318.
   PubMed Web of Science ®Google Scholar
• Nguyen TP, Kikuchi M, Vu TQ, et al. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis. 2008;2(10):e304.
   PubMed Web of Science ®Google Scholar
• Mercado ES, Espino FE, Perez ML, et al. HLA-A*33:01 as protective allele for severe dengue in a population of Filipino children. PLoS One. 2015;10(2):e0115619.
   Web of Science ®Google Scholar
• Vejbaesya S, Thongpradit R, Kalayanarooj S, et al. HLA Class I supertype associations with clinical outcome of secondary dengue virus infections in ethnic Thais. J Infect Dis. 2015;212(6):939–947.
   PubMed Web of Science ®Google Scholar
• Zellweger RM, Eddy WE, Tang WW, et al. CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J Immunol. 2014;193(8):4117–4124.
   PubMed Web of Science ®Google Scholar
• Zellweger RM, Shresta S. Mouse models to study dengue virus immunology and pathogenesis. Front Immunol. 2014;5:151.
   PubMed Web of Science ®Google Scholar
• Guy B, Nougarede N, Begue S, et al. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine. 2008;26(45):5712–5721.
   PubMed Web of Science ®Google Scholar
• Harenberg A, Begue S, Mamessier A, et al. Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore. Hum Vaccin Immunother. 2013;9(11):2317–2325.
   PubMed Web of Science ®Google Scholar
• Sabchareon A, Wallace D, Sirivichayakul C, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. 2012;380(9853):1559–1567.
   PubMed Web of Science ®Google Scholar
• Lindow JC, Durbin AP, Whitehead SS, et al. Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles. Vaccine. 2013;31(33):3347–3352.
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Angelo MA, Bangs DJ, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89(1):120–128.
   PubMed Web of Science ®Google Scholar
• Lindow JC, Borochoff-Porte N, Durbin AP, et al. Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans. PLoS Negl Trop Dis. 2012;6(7):e1742.
   PubMed Web of Science ®Google Scholar
• Chu H, George SL, Stinchcomb DT, et al. CD8+ T-cell responses in flavivirus-naive individuals following immunization with a live-attenuated tetravalent dengue vaccine candidate. J Infect Dis. 2015;212(10):1618–1628.
   Web of Science ®Google Scholar
• Waterman SH, Gubler DJ. Dengue fever. Clin Dermatol. 1989;7(1):117–122.
   PubMed Web of Science ®Google Scholar
• Basurko C, Alvarez EC, Djossou F, et al. The predictive value of a maculopapular rash in children hospitalized for dengue fever in Cayenne, French Guiana. Trans R Soc Trop Med Hyg. 2012;106(12):773–775.
   PubMed Web of Science ®Google Scholar
• Sandoval F, Terme M, Nizard M, et al. Mucosal imprinting of vaccine-induced CD8(+) T cells is crucial to inhibit the growth of mucosal tumors. Sci Transl Med. 2013;5(172):172ra120.
   Web of Science ®Google Scholar
• Liu L, Zhong Q, Tian T, et al. Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med. 2010;16(2):224–227.
   PubMed Web of Science ®Google Scholar